HIV 1-2 Ag/Ab selective and combined detection by a new rapid point-of-care test

Main Article Content

Marta Monari *
Serenella Valaperta
Eleonora Baldassarre
Roberto Assandri
Alessandro Montanelli
(*) Corresponding Author:
Marta Monari |


In order to reduce the window phase between time of human immunodeficiency virus (HIV) exposure and source’s results of laboratory investigations, we evaluated the analytical performance of a new point of care test for simultaneous detection of HIV Abs and HIV Ag.We tested 48 serum samples by HIV Combo Ag/Ab Abbott Diagnostic®, USA; by Western Blot Matrix HIV 1/2 Abbott®, USA and by the new POCT test HIV 1/2 Ag/Ab Combo Inverness Medical®, UK. Good concordance of results was recordered with analytical performance (sensitivity and specificity) and diagnostic accuracy of 100%.Thus this new test is ideal for rapid laboratory investigation when the time for appropriate prophylactic therapy is very important, such as found in exposure in the workplace.

Downloads month by month


Download data is not yet available.

Article Details

Most read articles by the same author(s)